Brain+ A/S (CPH:BRAINP)
0.0098
-0.0006 (-5.77%)
At close: Dec 5, 2025
Brain+ Market Cap
Brain+ has a market cap or net worth of 11.10 million as of December 5, 2025. Its market cap has decreased by -44.90% in one year.
Market Cap
11.10M
Enterprise Value
6.76M
Revenue
5.80M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since October 7, 2021, Brain+'s market cap has decreased from 51.99M to 11.10M, a decrease of -78.64%. That is a compound annual growth rate of -30.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 11.10M | -44.31% |
| Dec 30, 2024 | 19.94M | 56.98% |
| Dec 29, 2023 | 12.70M | -37.15% |
| Dec 30, 2022 | 20.21M | -50.00% |
| Dec 30, 2021 | 40.41M | -22.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,349.93B |
| Coloplast | 130.40B |
| Genmab | 124.62B |
| ALK-Abelló | 51.14B |
| Demant | 45.12B |
| H. Lundbeck | 41.69B |
| Zealand Pharma | 34.69B |
| Ambu A/S | 23.19B |